Efficacy of intravenous immunoglobulin in shrinking lung syndrome associated with mixed connective tissue disease: a case report.

Abstract

Shrinking lung syndrome is a rare manifestation of connective tissue diseases, namely systemic lupus erythematosus. It is characterised by reduced lung volumes and extra-pulmonary restrictive ventilatory pattern with good response to high-dose glucocorticoids alone or in combination with a second immunosuppressive agent. Here, we describe a case associated with mixed connective tissue disease and effectively treated with intravenous immunoglobulin.

Overview publication

TitleEfficacy of intravenous immunoglobulin in shrinking lung syndrome associated with mixed connective tissue disease: a case report.
Date2022-05-01
Issue nameClinical and experimental rheumatology
Issue numberv40 Suppl 134.5:116-117
DOI10.55563/clinexprheumatol/aotrf1
PubMed35084319
AuthorsSilvério-António M, Khmelinskii N & Fonseca JE
Read Read publication